{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:45:14Z","timestamp":1784904314001,"version":"3.55.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-23-CE14-0057"],"award-info":[{"award-number":["ANR-23-CE14-0057"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-23- 14\\u20130057CE"],"award-info":[{"award-number":["ANR-23- 14\\u20130057CE"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cyto.2025.156902","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T16:48:52Z","timestamp":1740415732000},"page":"156902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Evaluating the evidence for GM-CSF as a host-directed therapy in respiratory infections"],"prefix":"10.1016","volume":"189","author":[{"given":"Camille","family":"David","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Verney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Si-Tahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Guillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2025.156902_bb0005","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1152\/physrev.00032.2017","article-title":"Integrative physiology of Pneumonia","volume":"98","author":"Quinton","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cyto.2025.156902_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030076","article-title":"Lung Infection--a Public Health Priority","volume":"3","author":"Mizgerd","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0015","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00001432-200112000-00007","article-title":"Severe community-acquired Pneumonia: current outcomes, epidemiology, etiology, and therapy","volume":"14","author":"Restrepo","year":"2001","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.cyto.2025.156902_bb0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired Pneumonia requiring hospitalization among U.S. Adults","volume":"373","author":"Jain","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0025","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for Sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.cyto.2025.156902_bb0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1164\/rccm.202303-0558WS","article-title":"A new global Definition of acute respiratory distress syndrome","volume":"209","author":"Matthay","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0045","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(21)00630-9","article-title":"Community-acquired Pneumonia","volume":"398","author":"Aliberti","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2025.156902_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008965.pub4","article-title":"Neuraminidase Inhibitors for Preventing and Treating Influenza in Healthy Adults and Children","author":"Jefferson","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.cyto.2025.156902_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m3379","article-title":"A living WHO guideline on drugs for Covid-19","volume":"370","author":"Agarwal","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.cyto.2025.156902_bb0065","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.immuni.2022.08.010","article-title":"Biology of lung macrophages in health and disease","volume":"55","author":"Aegerter","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2025.156902_bb0070","doi-asserted-by":"crossref","DOI":"10.1172\/JCI170501","article-title":"Alveolar macrophages in tissue homeostasis, inflammation, and infection: evolving concepts of therapeutic targeting","volume":"133","author":"Malainou","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2025.156902_bb0075","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cell.2020.08.020","article-title":"Patrolling alveolar macrophages conceal Bacteria from the immune system to maintain homeostasis","volume":"183","author":"Neupane","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2025.156902_bb0080","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.cell.2018.09.042","article-title":"Induction of autonomous memory alveolar macrophages requires T cell help and is critical to trained immunity","volume":"175","author":"Yao","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2025.156902_bb0085","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.immuni.2013.04.004","article-title":"Tissue-resident macrophages Self-maintain locally throughout adult life with minimal contribution from circulating monocytes","volume":"38","author":"Hashimoto","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2025.156902_bb0090","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1074-7613(01)00218-7","article-title":"GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1","volume":"15","author":"Shibata","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2025.156902_bb0095","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.immuni.2016.10.026","article-title":"GM-CSF: from growth factor to central mediator of tissue inflammation","volume":"45","author":"Becher","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2025.156902_bb0100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nri2356","article-title":"Colony-stimulating factors in inflammation and autoimmunity","volume":"8","author":"Hamilton","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0105","first-page":"25","article-title":"Functions of Granulocyte-Macrophage Colony-Stimulating Factor","author":"Fleetwood","year":"2005","journal-title":"CRI"},{"key":"10.1016\/j.cyto.2025.156902_bb0110","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002044","article-title":"A review of GM-CSF therapy in Sepsis","volume":"94","author":"Mathias","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.cyto.2025.156902_bb0115","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.immuni.2017.10.007","article-title":"The cytokine TGF-\u03b2 promotes the development and homeostasis of alveolar macrophages","volume":"47","author":"Yu","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2025.156902_bb0120","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210745","article-title":"Alveolar macrophages rely on GM-CSF from alveolar epithelial type 2 cells before and after birth","volume":"218","author":"Gschwend","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0125","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1084\/jem.20131199","article-title":"Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF","volume":"210","author":"Guilliams","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0130","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210987","article-title":"CD116+ fetal precursors migrate to the perinatal lung and give rise to human alveolar macrophages","volume":"219","author":"Evren","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0135","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.4049\/jimmunol.147.4.1266","article-title":"Granulocyte-macrophage Colony-stimulating factor promotes the proliferation of human alveolar macrophages in vitro","volume":"147","author":"Nakata","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4049\/jimmunol.181.1.235","article-title":"Peroxisome proliferator-activated receptor-gamma regulates the expression of alveolar macrophage macrophage Colony-stimulating factor","volume":"181","author":"Bonfield","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fimmu.2018.00031","article-title":"The Activin A-peroxisome proliferator-activated receptor gamma Axis contributes to the transcriptome of GM-CSF-conditioned human macrophages","volume":"9","author":"Nieto","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583042","article-title":"Cross-talk between alveolar macrophages and lung epithelial cells is essential to maintain lung homeostasis","volume":"11","author":"Bissonnette","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0155","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1469-7580.2009.01190.x","article-title":"Distribution and expression of CD200 in the rat respiratory system under Normal and endotoxin-induced pathological conditions","volume":"216","author":"Jiang-Shieh","year":"2010","journal-title":"J. Anat."},{"key":"10.1016\/j.cyto.2025.156902_bb0160","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1349-7006.2006.00245.x","article-title":"CD47 regulation of epithelial cell spreading and migration, and its signal transduction","volume":"97","author":"Shinohara","year":"2006","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cyto.2025.156902_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2019.101842","article-title":"Inhibition of the PD-1\/PD-L1 signaling pathway enhances innate immune response of alveolar macrophages to mycobacterium tuberculosis in mice","volume":"60","author":"Hu","year":"2020","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.cyto.2025.156902_bb0170","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.imbio.2015.06.017","article-title":"Cell-contact dependent inhibition of monocytes by airway epithelial cells and reversion by infection with respiratory syncytial virus","volume":"220","author":"Oumouna","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.cyto.2025.156902_bb0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-immunol-032713-120142","article-title":"The interaction between signal regulatory protein alpha (SIRP\u03b1) and CD47: structure, function, and therapeutic target","volume":"32","author":"Barclay","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0180","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1164\/rccm.200812-1837OC","article-title":"Macrophage tumor necrosis factor-alpha induces epithelial expression of granulocyte-macrophage Colony-stimulating factor: impact on alveolar epithelial repair","volume":"180","author":"Cakarova","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nri3600","article-title":"Alveolar macrophages: plasticity in a tissue-specific context","volume":"14","author":"Hussell","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0190","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.coi.2009.09.004","article-title":"Pulmonary alveolar Proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages","volume":"21","author":"Trapnell","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0195","first-page":"L379","article-title":"GM-CSF regulates protein and lipid catabolism by alveolar macrophages","volume":"280","author":"Yoshida","year":"2001","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.cyto.2025.156902_bb0200","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1055\/s-0032-1325160","article-title":"Pulmonary alveolar Proteinosis","volume":"33","author":"Wang","year":"2012","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0205","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.3389\/fimmu.2021.752856","article-title":"The role of GM-CSF autoantibodies in infection and autoimmune pulmonary alveolar Proteinosis: a concise review","volume":"12","author":"Ataya","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0210","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1164\/rccm.200708-1271OC","article-title":"Characteristics of a large cohort of patients with autoimmune pulmonary alveolar Proteinosis in Japan","volume":"177","author":"Inoue","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0215","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/1074-7613(95)90046-2","article-title":"Mice deficient for the IL-3\/GM-CSF\/IL-5 Beta c receptor exhibit lung pathology and impaired immune response, while Beta IL3 receptor-deficient mice are Normal","volume":"2","author":"Nishinakamura","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2025.156902_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/s41590-022-01146-w","article-title":"Long-term culture-expanded alveolar macrophages restore their full epigenetic Identity after transfer in vivo","author":"Subramanian","year":"2022","journal-title":"Nat. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.cyto.2025.156902_bb0225","first-page":"173","article-title":"Activities of granulocyte-macrophage Colony-stimulating factor revealed by gene transfer and gene knockout studies","volume":"12","author":"Dranoff","year":"1994","journal-title":"Stem Cells"},{"key":"10.1016\/j.cyto.2025.156902_bb0230","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1089\/hgtb.2017.092","article-title":"Function and safety of lentivirus-mediated gene transfer for CSF2RA-deficiency","volume":"28","author":"Hetzel","year":"2017","journal-title":"Hum Gene Ther Methods"},{"key":"10.1016\/j.cyto.2025.156902_bb0235","article-title":"Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment","volume":"3","author":"Bosteels","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0240","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/cid\/ciu968","article-title":"Nocardia-induced granulocyte macrophage Colony-stimulating factor is neutralized by autoantibodies in disseminated\/Extrapulmonary Nocardiosis","volume":"60","author":"Rosen","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cyto.2025.156902_bb0245","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1165\/rcmb.2003-0148OC","article-title":"Peroxisome proliferator-activated receptor-\u03b3 is deficient in alveolar macrophages from patients with alveolar Proteinosis","volume":"29","author":"Bonfield","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.cyto.2025.156902_bb0250","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev.physiol.64.090601.113847","article-title":"GM-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense","volume":"64","author":"Trapnell","year":"2002","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.cyto.2025.156902_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-019-0066-3","article-title":"Pulmonary alveolar Proteinosis","volume":"5","author":"Trapnell","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.cyto.2025.156902_bb0260","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1073\/pnas.91.12.5592","article-title":"Granulocyte\/macrophage Colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology","volume":"91","author":"Stanley","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cyto.2025.156902_bb0265","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1038\/s42255-023-00921-9","article-title":"Efferocytosis-induced lactate enables the proliferation of pro-resolving macrophages to mediate tissue repair","volume":"5","author":"Ngai","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cyto.2025.156902_bb0270","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.cmet.2021.10.015","article-title":"Efferocytosis induces macrophage proliferation to help resolve tissue injury","volume":"33","author":"Gerlach","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.cyto.2025.156902_bb0275","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221388","article-title":"Trained immunity of alveolar macrophages enhances injury resolution via KLF4-MERTK-mediated Efferocytosis","volume":"220","author":"Chakraborty","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0280","article-title":"Role of GM-CSF in lung balance and disease","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0285","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1172\/JCI5212","article-title":"GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection","volume":"103","author":"LeVine","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2025.156902_bb0290","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.4049\/jimmunol.1101413","article-title":"Local delivery of GM-CSF protects mice from lethal pneumococcal Pneumonia","volume":"187","author":"Steinwede","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0295","first-page":"L571","article-title":"Lower respiratory tract delivery, airway clearance, and preclinical efficacy of inhaled GM-CSF in a Postinfluenza pneumococcal Pneumonia model","volume":"318","author":"Umstead","year":"2020","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.cyto.2025.156902_bb0300","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4049\/jimmunol.1800713","article-title":"GM-CSF Administration improves defects in innate immunity and Sepsis survival in obese diabetic mice","volume":"202","author":"Frydrych","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0305","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.4049\/jimmunol.1202526","article-title":"Anti-GM-CSF autoantibodies in patients with Cryptococcal meningitis","volume":"190","author":"Rosen","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0310","doi-asserted-by":"crossref","first-page":"e00912","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-granulocyte-macrophage Colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus Gattii in otherwise immunocompetent patients","volume":"5","author":"Saijo","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.cyto.2025.156902_bb0315","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.4049\/jimmunol.1501512","article-title":"Local GM-CSF-dependent differentiation and activation of pulmonary dendritic cells and macrophages protect against progressive Cryptococcal lung infection in mice","volume":"196","author":"Chen","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0320","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.190.6.875","article-title":"Idiopathic pulmonary alveolar Proteinosis as an autoimmune disease with neutralizing antibody against granulocyte\/macrophage Colony-stimulating factor","volume":"190","author":"Kitamura","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0325","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood-2003-05-1565","article-title":"High-affinity autoantibodies specifically eliminate granulocyte-macrophage Colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar Proteinosis","volume":"103","author":"Uchida","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2025.156902_bb0330","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood-2008-05-155689","article-title":"Granulocyte\/macrophage\u2013Colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects","volume":"113","author":"Uchida","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2025.156902_bb0335","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood-2003-05-1565","article-title":"High-affinity autoantibodies specifically eliminate granulocyte-macrophage Colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar Proteinosis","volume":"103","author":"Uchida","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2025.156902_bb0340","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/0140-6736(90)90665-R","article-title":"Development of antibodies to unprotected glycosylation sites on recombinant human GM-CSF","volume":"335","author":"Gribben","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2025.156902_bb0345","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2025.156902_bb0350","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3389\/fimmu.2020.01625","article-title":"Targeting GM-CSF in COVID-19 Pneumonia: rationale and strategies","volume":"11","author":"Bonaventura","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007360","article-title":"Alteration of Flt3-ligand-dependent de novo generation of conventional dendritic cells during influenza infection contributes to respiratory bacterial superinfection","volume":"14","author":"Beshara","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cyto.2025.156902_bb0360","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0132-2024","article-title":"The deadly dance of alveolar macrophages and influenza virus","volume":"33","author":"David","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.cyto.2025.156902_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004053","article-title":"Alveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infection","volume":"10","author":"Schneider","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cyto.2025.156902_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006140","article-title":"Alveolar macrophages prevent lethal influenza Pneumonia by inhibiting infection of Type-1 alveolar epithelial cells","volume":"13","author":"Cardani","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cyto.2025.156902_bb0375","article-title":"Innate immune response of human alveolar macrophages during influenza a infection","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2025.156902_bb0380","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1128\/JVI.02602-07","article-title":"Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs","volume":"82","author":"Kim","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2025.156902_bb0385","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.virol.2013.07.006","article-title":"The severe pathogenicity of alveolar macrophage-depleted ferrets infected with 2009 pandemic H1N1 influenza virus","volume":"444","author":"Kim","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.cyto.2025.156902_bb0390","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1128\/JVI.00291-10","article-title":"Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice","volume":"84","author":"Tate","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2025.156902_bb0395","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.antiviral.2011.08.022","article-title":"GM-CSF modulates pulmonary resistance to influenza a infection","volume":"92","author":"Sever-Chroneos","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.cyto.2025.156902_bb0400","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1164\/rccm.201012-2036OC","article-title":"GM-CSF in the lung protects against lethal influenza infection","volume":"184","author":"Huang","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0405","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12931-017-0708-5","article-title":"GM-CSF overexpression after influenza a virus infection prevents mortality and moderates M1-like airway monocyte\/macrophage polarization","volume":"19","author":"Halstead","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.cyto.2025.156902_bb0410","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/infdis\/jit830","article-title":"Protecting against Post-influenza bacterial Pneumonia by increasing phagocyte recruitment and ROS production","volume":"209","author":"Subramaniam","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cyto.2025.156902_bb0415","series-title":"The Aging Microenvironment Shapes Alveolar Macrophage Identity in Aging","first-page":"717033","author":"McQuattie-Pimentel","year":"2019"},{"key":"10.1016\/j.cyto.2025.156902_bb0420","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cyto.2010.04.001","article-title":"Protective effects of recombinant human granulocyte macrophage Colony stimulating factor on H1N1 influenza virus-induced Pneumonia in mice","volume":"51","author":"Huang","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2025.156902_bb0425","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaci.2015.09.031","article-title":"GM-CSF Treatment Prevents Respiratory Syncytial Virus\u2013Induced Pulmonary Exacerbation Responses in Postallergic Mice by Stimulating Alveolar Macrophage Maturation","volume":"137","author":"Naessens","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0430","first-page":"56","article-title":"Managing a deadly complication of influenza in older adults with comorbid disease","volume":"57","author":"Sethi","year":"2002","journal-title":"Geriatrics"},{"key":"10.1016\/j.cyto.2025.156902_bb0435","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4049\/jimmunol.1300014","article-title":"Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections","volume":"191","author":"Ghoneim","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0440","article-title":"Monocyte-derived alveolar macrophages autonomously determine severe outcome of respiratory viral infection","volume":"7, eabj5761","author":"Li","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0445","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4049\/jimmunol.1701406","article-title":"Effects of influenza on alveolar macrophage viability are dependent on mouse genetic strain","volume":"201","author":"Califano","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0450","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41590-019-0568-x","article-title":"Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection","volume":"21","author":"Aegerter","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0455","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159422","article-title":"Lethal synergy between SARS-CoV-2 and streptococcus pneumoniae in hACE2 mice and protective efficacy of vaccination","volume":"7","author":"Barman","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.cyto.2025.156902_bb0460","first-page":"L1210","article-title":"Impaired functional activity of alveolar Macrophages from GM-CSF-deficient mice","volume":"281","author":"Paine","year":"2001","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.cyto.2025.156902_bb0465","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.4049\/jimmunol.165.7.3934","article-title":"Distinct effects of surfactant protein a or D deficiency during bacterial infection on the Lung1","volume":"165","author":"LeVine","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0470","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood.V73.3.643.643","article-title":"Recombinant human granulocyte\/macrophage Colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor alpha and interferon in Cancer patients","volume":"73","author":"Wing","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2025.156902_bb0475","first-page":"L447","article-title":"TLR4-dependent GM-CSF protects against lung injury in gram-negative bacterial Pneumonia","volume":"302","author":"Standiford","year":"2012","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.cyto.2025.156902_bb0480","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40635-016-0096-z","article-title":"Sepsis modeling in mice: ligation length is a major severity factor in Cecal ligation and puncture","volume":"4","author":"Ruiz","year":"2016","journal-title":"Intensive Care Med. Exp."},{"key":"10.1016\/j.cyto.2025.156902_bb0485","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00000658-199407000-00010","article-title":"Granulocyte macrophage Colony-stimulating factor improves survival in two models of gut-derived Sepsis by improving gut barrier function and modulating bacterial clearance","volume":"220","author":"Gennari","year":"1994","journal-title":"Ann. Surg."},{"key":"10.1016\/j.cyto.2025.156902_bb0490","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/bjs.1800820618","article-title":"Granulocyte\u2013Macrophage Colony-Stimulating Factor Modulates Immune Function and Improves Survival after Experimental Thermal Injury","volume":"82","author":"Molloy","year":"1995","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.cyto.2025.156902_bb0495","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/jleuko\/qiad088","article-title":"Recombinant GM-CSF enhances the bactericidal ability of PMNs by increasing intracellular IL-1\u03b2 and improves the prognosis of secondary pseudomonas aeruginosa Pneumonia in Sepsis","volume":"114","author":"Tu","year":"2023","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cyto.2025.156902_bb0500","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13613-019-0543-6","article-title":"Preclinical septic shock research: why we need an animal ICU","volume":"9","author":"Guillon","year":"2019","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.cyto.2025.156902_bb0505","article-title":"A comprehensive evaluation of murine and human ex vivo cultured alveolar macrophages","author":"David","year":"2024","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.cyto.2025.156902_bb0510","article-title":"GM-CSF promotes immune response and survival in a mouse model of COVID-19","author":"Kendall","year":"2022","journal-title":"Res. Sq"},{"key":"10.1016\/j.cyto.2025.156902_bb0515","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40348-016-0055-5","article-title":"Lung epithelial GM-CSF improves host defense function and epithelial repair in influenza virus Pneumonia-a new therapeutic strategy?","volume":"3","author":"R\u00f6sler","year":"2016","journal-title":"Mol. Cell. Pediatr."},{"key":"10.1016\/j.cyto.2025.156902_bb0520","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0264-410X(02)00463-2","article-title":"A randomized, placebo-controlled trial of subcutaneous administration of GM-CSF as a vaccine adjuvant: effect on cellular and humoral immune responses","volume":"21","author":"Somani","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.cyto.2025.156902_bb0525","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1164\/rccm.201105-0833ED","article-title":"GM-CSF and influenza: will saving mice help humans?","volume":"184","author":"Waterer","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0530","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s00134-020-06170-8","article-title":"Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?","volume":"46","author":"Guillon","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0535","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJMoa1816216","article-title":"Inhaled GM-CSF for pulmonary alveolar Proteinosis","volume":"381","author":"Tazawa","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0540","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1056\/NEJMoa1913590","article-title":"Inhaled Molgramostim therapy in autoimmune pulmonary alveolar Proteinosis","volume":"383","author":"Trapnell","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0545","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13054-021-03513-9","article-title":"Lung compartmentalization of inflammatory biomarkers in COVID-19-related ARDS","volume":"25","author":"Jouan","year":"2021","journal-title":"Crit. Care"},{"key":"10.1016\/j.cyto.2025.156902_bb0550","doi-asserted-by":"crossref","first-page":"e2629","DOI":"10.1093\/milmed\/usac362","article-title":"Inhaled Sargramostim (recombinant human granulocyte-macrophage Colony-stimulating factor) for COVID-19-associated acute hypoxemia: results of the phase 2, randomized, open-label trial (iLeukPulm)","volume":"188","author":"Paine","year":"2023","journal-title":"Mil. Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0555","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cyto.2025.156902_bb0560","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jama.2020.17052","article-title":"Cytokine levels in critically ill patients with COVID-19 and other conditions","volume":"324","author":"Kox","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cyto.2025.156902_bb0565","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S2213-2600(20)30217-4","article-title":"Immunotherapies for COVID-19: lessons learned from Sepsis","volume":"8","author":"Remy","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0570","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S2213-2600(20)30267-8","article-title":"Therapeutic blockade of granulocyte macrophage Colony-stimulating factor in COVID-19-associated Hyperinflammation: challenges and opportunities","volume":"8","author":"Mehta","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0575","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1016\/S2665-9913(20)30170-3","article-title":"GM-CSF blockade with Mavrilimumab in severe COVID-19 Pneumonia and systemic Hyperinflammation: a single-Centre, Prospective Cohort Study","volume":"2","author":"De Luca","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.cyto.2025.156902_bb0580","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/bmt.2013.57","article-title":"First use of myeloid Colony-stimulating factors in humans","volume":"48","author":"Gale","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.cyto.2025.156902_bb0585","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1164\/rccm.202101-0030OC","article-title":"Early bacterial identification among intubated patients with COVID-19 or influenza Pneumonia: a European multicenter comparative clinical trial","volume":"204","author":"Rouz\u00e9","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-020-1089-y","article-title":"Predicting the microbial cause of community-acquired Pneumonia: can physicians or a data-driven method differentiate viral from bacterial Pneumonia at patient presentation?","volume":"20","author":"Lhommet","year":"2020","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0595","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00000421-199806000-00023","volume":"21","author":"Nemunaitis","year":"1998","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.cyto.2025.156902_bb0600","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.706186","article-title":"Sargramostim (Rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?","volume":"12","author":"Lazarus","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2025.156902_bb0605","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/cc10031","article-title":"Granulocyte-Colony stimulating factor (G-CSF) and granulocyte-macrophage Colony stimulating factor (GM-CSF) for Sepsis: a Meta-analysis","volume":"15","author":"Bo","year":"2011","journal-title":"Crit. Care"},{"key":"10.1016\/j.cyto.2025.156902_bb0610","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1378\/chest.127.6.2139","article-title":"Effect of granulocyte-monocyte Colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients","volume":"127","author":"Rosenbloom","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.cyto.2025.156902_bb0615","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/archsurg.141.2.150","article-title":"Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal Sepsis: a randomized, double-blind, Placebo-Controlled Clinical Trial","volume":"141","author":"Orozco","year":"2006","journal-title":"Arch. Surg."},{"key":"10.1016\/j.cyto.2025.156902_bb0620","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1164\/rccm.2009005","article-title":"A randomized phase II trial of granulocyte-macrophage Colony-stimulating factor therapy in severe Sepsis with respiratory dysfunction","volume":"166","author":"Presneill","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0625","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s00134-003-1666-6","article-title":"Reversal of Immunoparalysis by recombinant human granulocyte-macrophage Colony-stimulating factor in patients with severe Sepsis","volume":"29","author":"Nierhaus","year":"2003","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0630","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","article-title":"Granulocyte-macrophage Colony-stimulating factor to reverse Sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial","volume":"180","author":"Meisel","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0635","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/01.CCM.0000150835.66819.CA","article-title":"Human leukocyte antigen expression in Sepsis: what have we learned?*","volume":"33","author":"Tschoeke","year":"2005","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0640","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s00134-006-0205-7","article-title":"Is the measurement of monocytes HLA-DR expression useful in patients with Sepsis?","volume":"32","author":"Fumeaux","year":"2006","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2023.154330","article-title":"Granulocyte-macrophage Colony-stimulating factor (GM-CSF) in patients presenting Sepsis-induced immunosuppression: the GRID randomized controlled trial","volume":"78","author":"Vacheron","year":"2023","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.cyto.2025.156902_bb0650","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin Definition","volume":"307","author":"ARDS Definition Task Force","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.cyto.2025.156902_bb0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00003246-200001000-00001","article-title":"Modulation of neutrophil apoptosis by granulocyte Colony-stimulating factor and granulocyte\/macrophage Colony-stimulating factor during the course of acute respiratory distress syndrome","volume":"28","author":"Matute-Bello","year":"2000","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0660","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/CCM.0b013e31822d7bf0","article-title":"A randomized trial of recombinant human granulocyte-macrophage Colony stimulating factor for patients with acute lung injury","volume":"40","author":"Paine","year":"2012","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0665","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1164\/rccm.201311-2041LE","article-title":"Inhaled granulocyte\/macrophage Colony-stimulating factor as treatment of Pneumonia-associated acute respiratory distress syndrome","volume":"189","author":"Herold","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0670","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/23744235.2023.2254380","article-title":"Short-term inhalation of Sargramostim with concomitant high-dose steroids does not hasten recovery in moderate COVID-19 Pneumonia: a double-blind, randomised, Placebo-Controlled Trial","volume":"55","author":"Shimasaki","year":"2023","journal-title":"Infect. Dis. (Lond)"},{"key":"10.1016\/j.cyto.2025.156902_bb0675","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S2213-2600(21)00460-4","article-title":"Namilumab or infliximab compared with standard of Care in Hospitalised Patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, Proof-of-Concept Trial","volume":"10","author":"Fisher","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.cyto.2025.156902_bb0680","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/thoraxjnl-2017-211323","article-title":"Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosis","volume":"73","author":"Pinder","year":"2018","journal-title":"Thorax"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625000493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625000493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:40:48Z","timestamp":1778794848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466625000493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":133,"alternative-id":["S1043466625000493"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2025.156902","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the evidence for GM-CSF as a host-directed therapy in respiratory infections","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2025.156902","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"156902"}}